Serina Therapeutics, Inc.SERNYSE
Loading
Cost of Revenue Over TimeContracting
Percentile Rank22
5Y CAGR-47.7%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

5Y CAGR
-47.7%/yr
Long-term compound
Percentile
P22
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$50000.00-74.2%
2024$194000.00+115.6%
2023$90000.00-
2022$0.00-
2021$0.00-100.0%
2020$1.28M+28.3%
2019$998500.00+18.7%
2018$841000.00+22.8%
2017$685000.00-24.8%
2016$911000.00-